Cargando…

Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation

Detalles Bibliográficos
Autores principales: Schoots, Ivo G., Padhani, Anwar R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894174/
https://www.ncbi.nlm.nih.gov/pubmed/33089586
http://dx.doi.org/10.1111/bju.15277
_version_ 1783653192979972096
author Schoots, Ivo G.
Padhani, Anwar R.
author_facet Schoots, Ivo G.
Padhani, Anwar R.
author_sort Schoots, Ivo G.
collection PubMed
description
format Online
Article
Text
id pubmed-7894174
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78941742021-03-02 Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation Schoots, Ivo G. Padhani, Anwar R. BJU Int Research Communication John Wiley and Sons Inc. 2020-11-13 2021-02 /pmc/articles/PMC7894174/ /pubmed/33089586 http://dx.doi.org/10.1111/bju.15277 Text en © 2020 The Authors BJU International Published by John Wiley & Sons Ltd BJU International This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Communication
Schoots, Ivo G.
Padhani, Anwar R.
Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
title Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
title_full Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
title_fullStr Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
title_full_unstemmed Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
title_short Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
title_sort risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
topic Research Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894174/
https://www.ncbi.nlm.nih.gov/pubmed/33089586
http://dx.doi.org/10.1111/bju.15277
work_keys_str_mv AT schootsivog riskadaptedbiopsydecisionbasedonprostatemagneticresonanceimagingandprostatespecificantigendensityforenhancedbiopsyavoidanceinfirstprostatecancerdiagnosticevaluation
AT padhanianwarr riskadaptedbiopsydecisionbasedonprostatemagneticresonanceimagingandprostatespecificantigendensityforenhancedbiopsyavoidanceinfirstprostatecancerdiagnosticevaluation